National and Kapodistrian University of Athens
Νεότεροι παράγοντες αθηροσκλήρυνσης σε αιμοκαθερόμενους ασθενείς: μελέτη συσχέτισης σιαλικού οξέος με την αντίσταση στην ινσουλίνη σε αιμοκαθερόμενους ασθενείς
Abstract
dc:descriptionIntroduction: Cardiovascular (CV) disease is the most common cause of death in hemodialysis (HD) patients. Insulin resistance (IR), a disturbance in carbohydrate metabolism, which is frequently noted in such patients, is an important CV risk factor. Serum total sialic acid (STSA) is a CV morbidity and mortality risk factor in general population and in diabetics, however it has not been validated in HD patients in previous studies. Aim of the present study is to validate STSA as a marker of atherosclerosis, arterial stiffening and CV risk and to explore its possible association with IR in non-diabetic HD patients. Patients-Method: Seventy stable, non-diabetic HD patients (29 male and 41 female, aged 60.7±12.1) and 30 healthy controls (15 male and 15 female, aged 48.6±8.47) were included. Atherosclerosis and systemic arterial stiffening were evaluated by B-mode ultrasonography and Shygmocor (applanation tonometry), respectively. IR was quantified using HOMA index and STSA was measured with standard enzymatic colorimetric assay. After initial evaluation patients were followed-up for 28 months and CV events (fatal or not) were recorded. Results: Patients had higher STSA compared to healthy controls (age-sex adjusted p=0.018). In HD patients STSA correlated positively with markers of inflammation (CRP, fibrinogen, p<0.001), malnutrition (low serum albumin and creatinine, p=0.042), dyslipidemia (p=0.026) and atherosclerosis (intima-media wall thickness, p=0.05). Moreover, STSA correlated positively with IR (p=0.018), but the correlation was not independent of CRP and lipid concentrations. In our prospective study STSA was associated with increased CV risk in patients with positive (p=0.04) and in those with negative previous history for CV disease. However, in both groups CRP was a better marker of CV risk (p=0.001) Conclusions: Non-Diabetic HD patients present with higher STSA concentrations compared to healthy controls. Serum TSA is a marker of atherosclerosis, inflammation and CV risk in such patients, however its power in predicting CV risk is lower compared to CRP. Large prospective studies need to confirm our findings and to validate STSA as marker of CV risk in non-diabetic HD patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tseke, Paraskevi
- Τσεκέ, Παρασκευή
Subjects
dc:subject × 20- Σιαλικά οξέα
- Αθηροσκλήρυνση
- Χρόνια νεφρική ανεπάρκεια (ΧΝΑ)
- Καρδιαγγειακή νόσος
- Φλεγμονές
- Αιμοκάθαρση
- Ινσουλίνη, Αντίσταση στην
- Αρτηριοσκλήρωση
- Sialic acid
- Atherosclerosis
- End stage renal disease
- Cardiovascular disease
- Inflammation
- Hemodialysis
- Insulin resistance
- Arteriosclerosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18363